Target intelligence / Profile preview

Mitochondria-dependent apoptosis pathway

Molecular classification
Other (Signaling pathway)
01

Overview

The mitochondria-dependent apoptosis pathway (also called the mitochondrial or intrinsic apoptosis pathway) is a programmed cell death pathway controlled by mitochondrial signals. It is triggered by internal stressors such as DNA damage, oxidative stress, or lack of survival factors. Central to this pathway are Bcl-2 family proteins, which regulate mitochondrial outer membrane permeabilization (MOMP). Upon activation by pro-apoptotic factors (like Bax, Bak, Bad, Bid, Puma, Bim, and Noxa), mitochondria release cytochrome c and other proteins into the cytosol. Cytochrome c interacts with Apaf-1 to form the apoptosome, which activates initiator caspase-9, leading to a cascade that activates executioner caspases (mainly caspase-3, -6, and -7) and results in controlled cell dismantling. This pathway is frequently dysregulated in cancer and plays a critical role in tissue homeostasis and disease.

Other names
Mitochondrial apoptosis pathwayIntrinsic apoptosis pathwayIntrinsic pathway of apoptosis
02

Mechanism of action

Induction of mitochondrial outer membrane permeabilization (MOMP); Activation/inhibition of Bcl-2 family members (pro-apoptotic and anti-apoptotic); Promotion/release of cytochrome c to activate apoptosome and caspases

03

Biological functions

ApoptosisCell deathResponse to cellular stress
04

Disease associations

CancerNeurodegenerative diseaseCardiovascular diseaseDevelopmental disordersOther (Many normal and disease states where apoptosis dysregulation is central)
05

Safety considerations

Non-specific induction of apoptosis in healthy cellsRisk of tissue damage or organ toxicity due to excessive activation of the pathwayOff-target effects due to modulation of related pathways
06

Interacting drugs

Venetoclax (targets Bcl-2)

2 more in the full profile.

07

Biomarkers

Cytochrome c release (indicative of MOMP)Caspase-9 activationActivation of Bax/BakCleavage of PARPMitochondrial membrane potential loss (e.g. TMRE staining decrease)

Beyond the preview

Go deeper on Mitochondria-dependent apoptosis pathway.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitochondria-dependent apoptosis pathway.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call